PCLA:NASDAQPicoCELA Inc. Analysis
Data as of 2026-07-24 - not real-time
$5.19
Latest Price
8/10Risk
Risk Level: High
Executive Summary
PicoCELA Inc. (PCLA) is trading around $5.19, just above its 20‑day SMA (~$5.02) but below the 50‑day (~$5.18) and 200‑day (~$6.13) averages, signaling a bearish price trend. The RSI sits near 52, suggesting no immediate overbought/oversold condition, while the MACD line has crossed above its signal, offering a faint bullish hint that is outweighed by the overall “bearish” trend direction and a decreasing volume profile. Volatility is extreme at over 300% on a 30‑day basis and beta exceeds 1.6, indicating the stock moves sharply relative to the market.
Fundamentally, the company is under severe pressure: revenue fell 42% YoY, operating and net margins are deeply negative (over -100%), and both EBITDA and free cash flow are large negatives. Although cash on hand (~$535 M) exceeds debt (~$282 M), the cash burn remains high and the debt‑to‑equity ratio is near 60%, raising solvency concerns. Valuation metrics appear cheap – price‑to‑sales is under 0.1 and price‑to‑book is just above 2 – but these discounts reflect the deteriorating earnings and cash‑flow story rather than a genuine bargain. No dividend is paid, and the company’s ROE and ROA are strongly negative, underscoring the lack of sustainable profitability.
Fundamentally, the company is under severe pressure: revenue fell 42% YoY, operating and net margins are deeply negative (over -100%), and both EBITDA and free cash flow are large negatives. Although cash on hand (~$535 M) exceeds debt (~$282 M), the cash burn remains high and the debt‑to‑equity ratio is near 60%, raising solvency concerns. Valuation metrics appear cheap – price‑to‑sales is under 0.1 and price‑to‑book is just above 2 – but these discounts reflect the deteriorating earnings and cash‑flow story rather than a genuine bargain. No dividend is paid, and the company’s ROE and ROA are strongly negative, underscoring the lack of sustainable profitability.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below longer‑term moving averages
- Decreasing volume and high short‑term volatility
- Continued cash‑flow deficits
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Persistent revenue decline and negative margins
- Elevated debt burden relative to equity
- Uncertain path to profitability
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential upside if turnaround strategy succeeds
- Low price‑to‑sales ratio may attract value seekers
- High operational risk and need for structural improvements
Key Metrics & Analysis
Financial Health
Revenue Growth-42.30%
Profit Margin-114.98%
ROE-151.88%
ROA-32.38%
Debt/Equity59.91
P/B Ratio2.1
Op. Cash Flow$-544019968
Free Cash Flow$-412667616
Industry P/E15.3
Technical Analysis
TrendBearish
RSI51.8
Support$3.01
Resistance$11.56
MA 20$5.02
MA 50$5.18
MA 200$6.13
MACDBullish
VolumeDecreasing
Fear & Greed Index88.04
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.67
Volatility304.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.